Found 1467 results for "cancer"
For millions of women using hormonal contraception, a fundamental safety assumption may need revisiting. Meningiomas — typically slow-growing tumors arising fr…
For years, KRAS-mutant lung cancer has been one of oncology's most frustrating targets. While KRASG12C inhibitors transformed care for one mutation subtype, pa…
Understanding how lung cancer spreads has long been framed as a one-way journey from primary tumor to distant site. This landmark genomic study fundamentally c…
Drug resistance in metastatic breast cancer is not a dead end — it may actually be an exploitable vulnerability. A game-theoretic framework now suggests that t…
For clinicians and policymakers treating aging populations, the assumption that chronic disease is scattered and idiosyncratic is increasingly untenable. When…
For decades, roughly 80% of the human proteome was considered undruggable — proteins that conventional small molecules simply cannot inhibit effectively. A new…
For the roughly 400,000 people diagnosed globally each year with kidney cancer, the post-surgical window represents both the greatest opportunity and the most…
The idea that ordinary visible light could reshape the immune system's cancer-fighting capacity sounds implausible—until you consider that photoreceptors exist…
Most cancer immunology research focuses on T cells, checkpoint inhibitors, and tumor mutational burden — but the nervous system's direct role in dismantling an…
A largely overlooked fact about copper is that at supraphysiological concentrations it doesn't merely impair cells — it hijacks their own metabolic machinery a…
For the millions at elevated risk of head and neck cancer — including those with inherited DNA-repair deficiencies and, potentially, the general population — t…
For patients who undergo surgery to remove colorectal cancer that has spread to the liver, the critical question has always been: who actually needs chemothera…
The persistent gap in cancer mortality between men and women has long been attributed to lifestyle, biology, and healthcare utilization — but a large-scale sta…
For the millions of women diagnosed with breast cancer annually, the gap between a timely, accurate diagnosis and a missed or delayed one can be decisive. The…
One of the most frustrating realities in oncology is that immune checkpoint inhibitors — despite their revolutionary promise — fail the majority of patients wi…
For patients whose immune systems have turned against their own peripheral nerves — causing progressive weakness, numbness, and loss of mobility — existing tre…
Colorectal cancer remains one of the most preventable yet persistently lethal malignancies worldwide — largely because current screening tools fail at the inte…
Among 74 adults with HER2-positive breast cancer in Australia and the United States, nearly three-quarters (74.3%) expressed willingness to take cardioprotecti…
For decades, KRAS mutations were considered undruggable — a frustrating reality given that KRAS G12D is the dominant driver in pancreatic cancer and present in…
How a cancer cell dies turns out to matter enormously — not just for clearing the tumor, but for whether the immune system mounts a lasting defense. This disti…